20250230145. Crystalline Forms Carbazole Inhi (MBQ Pharma)
Appearance
CRYSTALLINE FORMS OF CARBAZOLE INHIBITORS OF RhoGTPase FOR THE TREATMENT OF DISEASE
Abstract: disclosed herein are crystalline forms of compounds for the inhibition of rhogtpase. also disclosed herein are compounds, pharmaceutical compositions, and methods of treatment of rhogtpase-mediated diseases, such as hyperproliferative and neoplastic diseases.
Inventor(s): Jocelyn M. JIMÉNEZ CRUZ, Vilmalí LÓPEZ-MEJÍAS, Torsten STELZER
CPC Classification: C07D403/04 (HETEROCYCLIC COMPOUNDS (macromolecular compounds ))
Search for rejections for patent application number 20250230145